Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFudan University

About this trial

Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.

Eligibility criteria

Qualifiers

All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.

Disqualifiers

Patients who have not been treated during hospitalization;

Patients with non-malignant tumors.

Trial design

Treatments tested in this trial

  • hospitalization

Treatment groups

500,000 Participants
are divided into 1 treatment group

Sponsors and collaborators